These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

15789 related items for PubMed ID: 25813885

  • 21. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H, Bharate GY, Daruwalla J.
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [Abstract] [Full Text] [Related]

  • 22. Nanooncology: the future of cancer diagnosis and therapy.
    Thakor AS, Gambhir SS.
    CA Cancer J Clin; 2013 Mar; 63(6):395-418. PubMed ID: 24114523
    [Abstract] [Full Text] [Related]

  • 23. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J, Huang Y, Kumar A, Tan A, Jin S, Mozhi A, Liang XJ.
    Biotechnol Adv; 2014 Mar; 32(4):693-710. PubMed ID: 24309541
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F.
    Curr Med Chem; 2018 Mar; 25(34):4224-4268. PubMed ID: 28875844
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R, Mongia P, Kumar Sahu S, Ram A.
    Curr Drug Targets; 2016 Mar; 17(2):206-28. PubMed ID: 26201484
    [Abstract] [Full Text] [Related]

  • 30. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT, Roger E, Lautram N, Benoît JP, Passirani C.
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J, Chomoucka J, Adam V, Ryvolova M, Eckschlager T, Hubalek J, Kizek R.
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [Abstract] [Full Text] [Related]

  • 33. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M.
    Int J Nanomedicine; 2021 Jun; 16():1313-1330. PubMed ID: 33628022
    [Abstract] [Full Text] [Related]

  • 34. Magnetic therapeutic delivery using navigable agents.
    Martel S.
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [Abstract] [Full Text] [Related]

  • 35. The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.
    Lee WH, Loo CY, Leong CR, Young PM, Traini D, Rohanizadeh R.
    Expert Opin Drug Deliv; 2017 Aug; 14(8):937-957. PubMed ID: 27759437
    [Abstract] [Full Text] [Related]

  • 36. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
    Wang ZQ, Liu K, Huo ZJ, Li XC, Wang M, Liu P, Pang B, Wang SJ.
    J Nanobiotechnology; 2015 Oct 01; 13():63. PubMed ID: 26427800
    [Abstract] [Full Text] [Related]

  • 37. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E, Horodecka K, Shcharbin D, Bryszewska M.
    Curr Med Chem; 2021 Oct 01; 28(2):346-359. PubMed ID: 32000637
    [Abstract] [Full Text] [Related]

  • 38. Targeting liposomes toward novel pediatric anticancer therapeutics.
    Federman N, Denny CT.
    Pediatr Res; 2010 May 01; 67(5):514-9. PubMed ID: 20118828
    [Abstract] [Full Text] [Related]

  • 39. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD, Mayer LD.
    Ther Deliv; 2014 Feb 01; 5(2):149-71. PubMed ID: 24483194
    [Abstract] [Full Text] [Related]

  • 40. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
    Gupta M, Agrawal GP, Vyas SP.
    Curr Mol Med; 2013 Jan 01; 13(1):179-204. PubMed ID: 22834834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 790.